Grace Therapeutics (GRCE) News Today $3.20 +0.14 (+4.58%) As of 09/5/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock GRCE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 4 at 8:00 AM | globenewswire.comGrace Therapeutics (NASDAQ:GRCE) Stock Rating Lowered by Wall Street ZenAugust 31, 2025 | americanbankingnews.comGrace Therapeutics, Inc.: Grace Therapeutics Announces U.S. Food and Drug Administration Acceptance for Review of New Drug Application for GTx-104August 27, 2025 | finanznachrichten.deGrace Therapeutics Announces U.S. Food and Drug Administration Acceptance for Review of New Drug Application for GTx-104August 27, 2025 | globenewswire.comGRCE: Looking Ahead to AcceptanceAugust 13, 2025 | finance.yahoo.comGrace Therapeutics Reports Q2 2025 Earnings and Strategic FocusAugust 13, 2025 | msn.comGrace Therapeutics, Inc.: Grace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business UpdateAugust 12, 2025 | finanznachrichten.deGrace Therapeutics, Inc. Submits NDA to FDA for GTx-104 Treatment of Aneurysmal Subarachnoid Hemorrhage Following Positive Phase 3 Trial ResultsAugust 12, 2025 | quiverquant.comQGrace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business UpdateAugust 12, 2025 | globenewswire.comGRCE: NDA SubmittedJune 26, 2025 | msn.comGrace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104June 25, 2025 | globenewswire.comGrace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update - MorningstarJune 24, 2025 | morningstar.comMGRACE THERAPEUTICS Earnings Preview: Recent $GRCE Insider Trading, Hedge Fund Activity, and More - NasdaqJune 24, 2025 | nasdaq.comGrace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near FutureJune 24, 2025 | finance.yahoo.comGrace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business UpdateJune 23, 2025 | globenewswire.comGrace Therapeutics to Participate in the 2025 BIO International ConferenceJune 13, 2025 | globenewswire.comGRCE: Progress ReportJune 5, 2025 | msn.comGRCE Grace Therapeutics, Inc.June 1, 2025 | seekingalpha.comThis Grace Therapeutics Insider Increased Their Holding By 12% Last YearMay 25, 2025 | finance.yahoo.comBiotech Stock Ends Week On High Note Following Bullish Coverage InitiationMay 2, 2025 | msn.comGrace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104April 9, 2025 | globenewswire.comGrace Therapeutics files to sell 8.84M shares of common stock for holdersMarch 10, 2025 | markets.businessinsider.comGrace Therapeutics Files Form S-3 for Flexible Securities OfferingMarch 10, 2025 | tipranks.comGrace Therapeutics to Participate in the TD Cowen 45th Annual Health Care ConferenceFebruary 25, 2025 | globenewswire.comGRCE: STRIVE-ON Results ReportedFebruary 21, 2025 | finance.yahoo.comGrace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business UpdateFebruary 13, 2025 | markets.businessinsider.comGrace Therapeutics reports Q3 EPS (36c), consensus (46c)February 13, 2025 | markets.businessinsider.comGrace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business UpdateFebruary 13, 2025 | globenewswire.comGrace Therapeutics secures $15m for GTx-104 pre-commercial developmentFebruary 11, 2025 | finance.yahoo.comGrace Therapeutics price target raised to $11 from $8 at Craig-HallumFebruary 11, 2025 | markets.businessinsider.comCraig-Hallum Sticks to Its Buy Rating for Grace Therapeutics (GRCE)February 11, 2025 | markets.businessinsider.comGrace Therapeutics, Inc.: Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAHFebruary 10, 2025 | finanznachrichten.deGrace Therapeutics reports positive Phase 3 trial results for GTx-104February 10, 2025 | msn.comGrace Therapeutics secures up to $30 million financingFebruary 10, 2025 | msn.comGrace Therapeutics announces private placement financing of up to $30MFebruary 10, 2025 | markets.businessinsider.comGrace Therapeutics announces results from Phase 3 STRIVE-ON trialFebruary 10, 2025 | markets.businessinsider.comGrace Therapeutics Announces Private Placement Financing of up to $30 MillionFebruary 10, 2025 | globenewswire.comGrace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAHFebruary 10, 2025 | globenewswire.comCraig-Hallum Reaffirms Their Buy Rating on Grace Therapeutics (GRCE)January 30, 2025 | markets.businessinsider.com3 US Penny Stocks With Market Cap Under $70MJanuary 23, 2025 | finance.yahoo.comGrace Therapeutics Inc Ordinary SharesJanuary 10, 2025 | morningstar.comM Get Grace Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRCE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GRCE Media Mentions By Week GRCE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRCE News Sentiment▼-0.170.72▲Average Medical News Sentiment GRCE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRCE Articles This Week▼21▲GRCE Articles Average Week Get the Latest News and Ratings for GRCE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Grace Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MEI Pharma News Nuvectis Pharma News Lifevantage News Actuate Therapeutics News biote News Seres Therapeutics News Citius Oncology News Black Diamond Therapeutics News Kyverna Therapeutics News Nkarta News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRCE) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredOdd “310F trade” doubles investor’s money in just 3 days?Have you heard of 310F? This unusual trade setup has quietly delivered one of the most consistent profit st...Eagle Publishing | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
